Tagged with bio tech

SaxoTV

Van-Petersen: Key currency crosses to look at...

729 views November 30, 2015

With so many central banks meeting this week, Saxo's Kay Van-Petersen discusses the currency...

SaxoTV

Garnry: Why no-one is talking about the crash...

843 views October 01, 2015

Biotechnology stocks have fallen significantly since their July peak. But because of the noise...

SaxoTV

Berger: Biotech ETFs bubbling higher

370 views May 28, 2015

The massive rally in the biotechnology sector is not over according to Serge Berger, also known...

SaxoTV

Earnings Season: GSK will disappoint but pharma...

382 views May 05, 2015

Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...

SaxoTV

Berger: NASDAQ biotechnology sector overextended

427 views March 06, 2015

Serge Berger, who is also known as The Steady Trader, believes the NASDAQ Biotechnology ETF...

SaxoTV

It's Nasdaq Week - here's Peter Garnry's guide...

540 views November 24, 2014

It's the largest US stock exchange in terms of volume and market share and the Nasdaq is...

SaxoTV

Berger: Biogen's healthy recovery

152 views July 24, 2014

Serge Berger suggests buying Biogen, a biotech firm which has reported sales of its Multiple...

SaxoTV

Just what is Monsanto up to?

1,321 views June 24, 2014

It’s been revealed that talks between US agricultural giant Monsanto and its rival Syngenta have...

SaxoTV

Why Monsanto is sowing the seeds of its future

175 views June 13, 2014

Agricultural giant Monsanto will maintain its competitive advantage according to research company...

SaxoTV

Why Tech and Biotech are making a comeback

257 views May 28, 2014

Because markets have been choppy over the past few months, Swiss-based Trader Serge Berger, also...

SaxoTV

Buying the biotech boost

209 views May 06, 2014

Leading Bio tech firms, have seen around thirty percent growth in the last year and prospects...

SaxoTV

Medical stocks - a healthy investment?

544 views April 11, 2014

The US healthcare sector is booming due to a combination of Obamacare and the approval of new...